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Activation of FOXO1 by Cdk1 in Cycling
Cells and Postmitotic Neurons
Zengqiang Yuan,1*† Esther B. E. Becker,1* Paola Merlo,1 Tomoko Yamada,1 Sara DiBacco,1
Yoshiyuki Konishi,1 Erik M. Schaefer,2 Azad Bonni1‡
Activation of cyclin-dependent kinase 1 (Cdk1) has been linked to cell death of postmitotic neurons
in brain development and disease. We found that Cdk1 phosphorylated the transcription factor FOXO1
at Ser249 in vitro and in vivo. The phosphorylation of FOXO1 at Ser249 disrupted FOXO1 binding with
14-3-3 proteins and thereby promoted the nuclear accumulation of FOXO1 and stimulated FOXO1-
dependent transcription, leading to cell death in neurons. In proliferating cells, Cdk1 induced FOXO1
Ser249 phosphorylation at the G2/M phase of the cell cycle, resulting in FOXO1-dependent expression
of the mitotic regulator Polo-like kinase (Plk). These findings define a conserved signaling link
between Cdk1 and FOXO1 that may have a key role in diverse biological processes, including
the degeneration of postmitotic neurons.
The protein kinase Cdk1 is a key mediatorof neuronal cell death that is relevant tobrain development and degeneration (1–6).
As a major apoptotic kinase, Cdk1 might be
expected to orchestrate a program of gene ex-
pression that activates the cell death machinery.
Because Cdk1 resides in the cytoplasm in neu-
rons (1, 5, 6), we reasoned that Cdk1 might regu-
late gene expression through proteins that shuttle
between the cytoplasm and nucleus. The FOXO
transcription factors undergo nucleocytoplasmic
shuttling and control cell death (7, 8). We there-
fore investigated the role of FOXO proteins in
propagating the Cdk1 cell death signal to the
nucleus in postmitotic neurons.
FOXO1 contains a conserved putative Cdk1
phosphorylation site within the forkhead domain
at Ser249 (fig. S1A). Cdk1 catalyzed the phospho-
rylation of FOXO1 in vitro (Fig. 1A) (9). Cdk1
also phosphorylated the FOXO1 forkhead do-
main (FOXO1FD) in vitro, but failed to phos-
phorylate a FOXO1FD mutant in which Ser249
was replaced with alanine (FOXO1FD S249A)
(fig. S1B). We generated an antibody that spe-
cifically recognizes FOXO1 that is phosphoryl-
ated at Ser249 (9). The phosphoS249-FOXO1
antibody recognized recombinant FOXO1 or
FOXO1FD that was phosphorylated by Cdk1 in
vitro but did not recognize unphosphorylated
FOXO1 or the FOXO1FD S249A mutant that
was incubated with Cdk1 in vitro (Fig. 1B and
fig. S1C). We expressed cyclin B and Cdk1 in
293T cells together with FOXO1 or a S249A
FOXO1 mutant. Immunoblotting of total lysates
or FOXO1 immunoprecipitates of transfected cells
revealed that Cdk1 increased the amount of phos-
phorylated FOXO1 at Ser249 in cells (Fig. 1C and
fig. S1D). In other experiments, depletion of endog-
enous Cdk1 byRNA interference (RNAi) reduced
the FOXO1 phosphorylation in cells (Fig. 1D
and fig. S1E), which suggested a requirement for
endogenous Cdk1 in the FOXO1 phosphoryl-
ation at Ser249 in cells.
We tested whether the activation of endoge-
nous Cdk1 induced the phosphorylation of endog-
enous FOXO1 at Ser249 in neurons. Endogenous
Cdk1 is activated in cerebellar granule neurons
upon inhibition ofmembrane depolarization (1, 3).
We found that the amount of FOXO1 Ser249
phosphorylation was higher in neurons deprived
of membrane-depolarizing concentrations of KCl
(5 mM KCl) than in neurons maintained in de-
polarizing medium (30 mM KCl) (Fig. 1E). The
Cdk1 inhibitor roscovitine reduced the FOXO1
Ser249 phosphorylation in neurons deprived of
depolarization (Fig. 1E). Thus, endogenous Cdk1
appears to mediate activity deprivation–induced
phosphorylation of endogenous FOXO1 at Ser249
in neurons.
The identification of Cdk1-induced phospho-
rylation of FOXO1 at Ser249 led us to test wheth-
er the FOXO1 phosphorylation mediated the
ability of Cdk1 to trigger cell death in neurons.
Because endogenous Cdk1 is required for apo-
ptosis of activity-deprived neurons (1, 3), we de-
termined the role of FOXO1 in apoptosis of
neurons deprived of activity. We transfected
neurons with the U6/foxo RNAi or control U6
plasmid. FOXO RNAi reduced the expression of
FOXO1 in primary granule neurons and
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Fig. 1. Cdk1 phosphorylates
FOXO1 at Ser249. (A) Recom-
binant cyclin B, Cdk1, and full-
length glutathione S-transferase
(GST)–FOXO1 were subjected
to an in vitro kinase assay (9).
(B) Recombinant GST or GST-
FOXO1, together with cyclin B
and Cdk1, were subjected to
an in vitro kinase assay and
were immunoblotted with the
phosphoS249-FOXO1 or GST
antibody. Asterisks indicateGST-
FOXO1 degradation products. (C) Lysates of 293T cells transfected with cyclin B and Cdk1 or the control
vector, together with the green fluorescent protein (GFP) fusion protein GFP-FOXO1 or the GFP-FOXOS249A
mutant, were immunoblotted with the phosphoS249-FOXO1 antibody or a mouse monoclonal FOXO1
antibody. (D) Lysates of Neuro2A cells transfected with the control U6 or U6/cdk1 RNAi plasmid and GFP-
FOXO1 were immunoprecipitated with the GFP antibody and immunoblotted with the phosphoS249-
FOXO1 antibody. Lysates were also immunoblotted with the GFP or Cdk1 antibody. (E) Lysates of granule
neurons maintained in membrane-depolarizing medium (30 mM KCl) or in which depolarization was
inhibited (5 mM KCl) in the presence of the Cdk1 inhibitor roscovitine (10 mM) or its vehicle [dimethyl
sulfoxide (DMSO)] were immunoblotted with the phosphoS249-FOXO1 or FOXO1 antibody.
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Fig. 2. Cdk1-FOXO1 signalingmediates activity deprivation–induced neuronal
death. (A) Granule neurons transfected with the U6/foxo RNAi or control U6
plasmid were placed in membrane-depolarizing medium (30 mM KCl) or
deprived of membrane depolarization (5 mM KCl) for 30 hours and subjected to
analysis of cell death (9). FOXO RNAi attenuated activity deprivation–induced
neuronal cell death [mean ± SEM, n = 4; P < 0.005, analysis of variance
(ANOVA) followed by Fisher’s PLSD post hoc test] but not cell death in
depolarized neurons (see also fig. S2C). (B) Granule neurons transfected with
the U6/foxo RNAi or control U6 plasmid, together with cyclin B and Cdk1 or the
control vector, were analyzed as in (A). FOXO RNAi inhibited cyclin B and Cdk1–
induced cell death (mean ± SEM, n = 3; P < 0.005, ANOVA followed by Fisher’s
PLSD post hoc test). (C) Lysates of COS cells transfected with the U6/foxo RNAi
or control U6 plasmid together with FOXO1 or an RNAi-resistant rescue form of
FOXO1 (FOXO1-Res) were immunoblotted with a FOXO1 or 14-3-3 antibody
(9). (D) Granule neurons transfected with the U6/foxo RNAi plasmid together
with FOXO1-Res or the FOXO1-ResS249A mutant were analyzed as in (A).
FOXO1-Res, but not FOXO1-ResS249A, induced cell death in activity-deprived
neurons in the background of FOXO RNAi (mean ± SEM, n = 3; P < 0.05,
ANOVA followed by Fisher’s PLSD post hoc test).
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Fig. 3. FOXO1 Ser249 phospho-
rylation disrupts the FOXO1–14-
3-3 interaction and promotes
nuclear accumulation of FOXO1,
leading to activation of transcrip-
tion. (A) Lysates of 293T cells
transfected with GFP-FOXO1 or
GFP-FOXO1S249A, together with
cyclin B and Cdk1 or the control
vector, were immunoprecipitated
with the GFP antibody and im-
munoblotted with the 14-3-3 or
phosphoS249-FOXO1 antibody.
Lysates were also immunoblotted
with the GFP or 14-3-3 antibody.
(B) Lysates of granule neurons
maintained in depolarizing medi-
um (30 mM KCl) or deprived of
depolarization (5 mM KCl), in the
presence of the Cdk1 inhibitor
roscovitine (10 mM) or its vehicle
(DMSO), were immunoprecipitated
with the FOXO1 antibody and im-
munoblotted with the 14-3-3 an-
tibody. Lysates were immunoblotted
with the phosphoS249-FOXO1 or
14-3-3 antibody. (C) Granule neu-
rons transfected with GFP-FOXO1
together with the U6/cdk1 RNAi or
control U6 plasmid maintained in
depolarizing medium (30 mM KCl)
or deprived of depolarization (5
mM KCl) were analyzed by fluo-
rescence microscopy. Represent-
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ative images are shown (left, GFP-FOXO1; center, Hoechst;
right, merged). Arrowheads indicate neurons displaying nu-
clear localization of GFP-FOXO1. Scale bar, 10 mm. (D)
Lysates of granule neurons transfected with GFP-FOXO1,
GFP-FOXO1S249A, or the control vector and depolarized
(30 mM KCl) or deprived of depolarization (5 mM KCl) were
immunoblotted with the BIM, Erk1/2, or FOXO1 antibody. (E) Granule neurons
transfected with the U6/cdk1 RNAi or control U6 plasmid together with the
3xIRS-luciferase (left) or BIM-luciferase (right) reporter gene and tk-renilla were
deprived of depolarization and subjected to luciferase assays. Cdk1 knockdown
reduced the expression of the 3xIRS (mean ± SEM, n = 3; P < 0.001, t test) and
BIM-luciferase (mean ± SEM, n = 3; P < 0.005, t test) reporter gene.
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protected neurons against cell death induced by
suppression of depolarization (Fig. 2A and fig.
S2A) (9). FOXO RNAi also suppressed the
ability of expression of cyclin B and Cdk1 to
induce cell death in neurons (Fig. 2B). To
determine the importance of the phosphorylation
of FOXO1 at Ser249 in activity deprivation–
induced neuronal apoptosis, we constructed an
expression plasmid encoding an RNAi-resistant
form of FOXO1 (FOXO1-Res) (9). Whereas
FOXO RNAi induced depletion of FOXO1 en-
coded by wild-type cDNA, FOXO RNAi failed
to induce efficient depletion of FOXO1-Res
(Fig. 2C). Expression of FOXO1-Res triggered
apoptosis in FOXO-depleted neurons deprived of
activity (Fig. 2D). By contrast, a FOXO1-Res
mutant in which Ser249 was replaced with alanine
(FOXO1-ResS249A) failed to effectively induce
neuronal cell death in the background of FOXO
RNAi (Fig. 2D). Thus, the Ser249 phosphoryl-
ation appears to be required for the ability of
FOXO1 to mediate activity deprivation–induced
neuronal apoptosis.
We characterized the mechanism by which
the Cdk1-induced phosphorylation of FOXO1 at
Ser249 stimulates FOXO1-dependent neuronal cell
death. Ser249 lies within a conserved short FOXO1
peptide motif that includes the Akt site of phos-
phorylation, Ser256 (fig. S1A). Because Ser256-
phosphorylated FOXO1 interacts with 14-3-3
proteins, leading to FOXO1’s cytoplasmic seques-
tration and inhibition (7, 8), we tested whether
phosphorylation of FOXO1 at Ser249 might reg-
ulate FOXO1’s interaction with 14-3-3 proteins.
Although FOXO1 or its forkhead domain in-
teracted efficiently with 14-3-3 proteins, expres-
sion of Cdk1 reduced these interactions (Fig. 3A
and fig. S3A). However, Cdk1 failed to inhibit
the interaction of FOXO1S249Awith 14-3-3 pro-
teins (Fig. 3A). Cdk1 did not affect Ser256 phos-
phorylation in FOXO1 or its forkhead domain
(fig. S3, A and B), which suggests that the Ser249
phosphorylation inhibits the interaction of Ser256-
phoshorylated FOXO1 with 14-3-3 proteins.
To ascertain whether endogenousCdk1might
regulate the interaction of endogenous FOXO1
with 14-3-3 proteins in neurons, we assayed the
association of these proteins in granule neurons
in the presence or absence of membrane depo-
larization. In depolarized neurons, endogenous
FOXO1 interacted with endogenous 14-3-3 pro-
teins (Fig. 3B). However, withdrawal of depolar-
ization, which stimulates the activity of endogenous
Cdk1 in neurons (1, 3), reduced the interaction
(Fig. 3B). The Cdk1 inhibitor roscovitine blocked
the ability of activity deprivation to disrupt FOXO1’s
association with 14-3-3 proteins (Fig. 3B). These
findings suggest that endogenous Cdk1-induced
phosphorylation of FOXO1 at Ser249 releases
FOXO1 from sequestration by 14-3-3 proteins in
neurons.
Because 14-3-3 proteins sequester FOXO
proteins in the cytoplasm (7, 8), we characterized
the consequences of the Ser249 phosphorylation
on the subcellular localization of FOXO1.Whereas
FOXO1was localized predominantly in the cyto-
plasm in depolarized neurons, FOXO1 accumu-
lated in the nucleus in neurons deprived of
activity (Fig. 3C and fig. S4, A to C). Depletion
of endogenous Cdk1 by RNAi reduced the nu-
clear accumulation of FOXO1 in activity-deprived
neurons (Fig. 3C and fig. S4, A to C). In other
experiments, expression of cyclin B and Cdk1
triggered the nuclear accumulation of wild-type
FOXO1but not FOXO1S249A in neurons (fig. S5).
These results suggest that Cdk1-induced phos-
phorylation of FOXO1 Ser249 stimulates the nu-
clear accumulation of FOXO1 in neurons.
The finding that Ser249-phosphorylated
FOXO1 accumulates in the nucleus led us to test
whether Cdk1-FOXO1 signaling might activate
FOXO-dependent transcription. Overexpression
of Cdk1 augmented the ability of FOXO1, but
not of FOXO1S249A, to stimulate the expression
of a luciferase reporter gene controlled by a
FOXO-responsive promoter (3xIRS-luciferase) in
granule neurons (fig. S6) (9).Withdrawal of mem-
brane depolarization induced the endogenous
expression of the FOXO-responsive apoptotic
gene BIM in granule neurons (Fig. 3D). Expres-
sion of FOXO1S249A, but not of FOXO1, reduced
the induction of endogenous BIM expression
upon activity deprivation (Fig. 3D). Depletion
of endogenous Cdk1 by RNAi in neurons re-
duced the expression of both the 3xIRS-luciferase
reporter gene and a reporter gene controlled by
the BIM promoter (Fig. 3E). Together, these
results suggest that endogenous Cdk1-induced
phosphorylation of FOXO1 at Ser249 stimulates
FOXO1-dependent transcription, leading to BIM
expression and consequent neuronal cell death.
Overexpression of the Cdk1-related protein
kinaseCdk2was reported tophosphorylateFOXO1
at Ser249, thereby inducing the nuclear exclusion
and inhibition of FOXO1 in prostate cancer cells
(10). We found that overexpression of Cdk2 or
Cdk1 stimulated FOXO1-dependent transcription
and failed to promote the nuclear export of
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Fig. 4. Endogenous Cdk1-FOXO1 signaling stim-
ulates Plk expression in proliferating cells. (A to F)
NIH 3T3 fibroblast cells were synchronized by
contact inhibition (CI) or treatment with nocoda-
zole (Noc) as described (9) and were analyzed for
DNA content by flow cytometry. (A) Representative
profiles. (B) Lysates of synchronized NIH 3T3 cells
were immunoblotted with phosphoS249-FOXO1,
Plk1, cyclin B, FOXO1, or Erk1/2 antibody. (C) Lysates of NIH 3T3 cells synchronized in G2/M were fractionated into cytoplasmic and nuclear components and
immunoblotted with the FOXO1, phosphoS249-FOXO1, SP1, or 14-3-3 antibody. The 14-3-3 and SP1 proteins indicate the cytoplasmic and nuclear
compartments, respectively. (D) NIH 3T3 cells transfected with 3xIRS-luciferase reporter gene and synchronized as in (A) were subjected to luciferase assay.
FOXO-dependent reporter expression was increased in G2/M-enriched relative to G0/G1-enriched NIH 3T3 cells (mean ± SEM, n = 5; P < 0.01, t test). (E) The
amount of Plk mRNA was induced in G2/M-enriched relative to G0/G1-enriched NIH 3T3 cells (mean ± SEM, n = 3; P < 0.001, t test). (F) Chromatin
immunoprecipitation analysis of synchronized NIH 3T3 cells, using a rabbit immunoglobulin G control or a FOXO1 antibody. (G) NIH 3T3 cells transfected with
U6-GFP/foxo RNAi or U6-GFP control RNAi plasmid were sorted on the basis of GFP expression. Lysates of sorted cells were immunoblotted with the Plk, FOXO1,
or ERK1/2 antibody. (H) NIH 3T3 cells transfected with U6-GFP/foxo RNAi plasmid and FOXO1-Res or FOXO1-ResS249A were sorted on the basis of GFP
expression. Lysates of sorted cells were analyzed as in (G).
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FOXO1 in diverse cell types, including prostate
cancer cells (figs. S7 and S8) (9). We confirmed
that overexpression of Cdk2 induced phospho-
rylation of FOXO1 at Ser249 (fig. S9A). However,
the FOXO1 Ser249 phosphorylation was not re-
duced in Cdk2-deficient fibroblasts (fig. S9, B
and C) (9), which suggests that endogenous Cdk2
may not be uniquely required for the FOXO1
Ser249 phosphorylation in proliferating cells.
To determine the consequences of endoge-
nous FOXO1 Ser249 phosphorylation in pro-
liferating cells, we characterized the FOXO1
phosphorylation in distinct phases of the cell
cycle in which Cdk1 activity is low (G0 or G1) or
high (G2/M) in synchronized DU145 prostate
cancer cells (fig. S10),NIH3T3 fibroblasts (Fig. 4),
andmurine embryonic fibroblasts (MEFs) (fig. S11).
Endogenous FOXO1 phosphorylation was low
in cells enriched for the G0 or G1 phase and high
in cells enriched for the G2/M transition of the
cell cycle (Fig. 4B and figs. S10B, S11B, and
S12). These findings suggest that phosphoryl-
ation of endogenous FOXO1 at Ser249 coincides
with endogenous Cdk1 activity in the cell cycle.
We assessed the effect of phosphorylation of
endogenous FOXO1 at Ser249 on the subcellular
localization of FOXO1 in proliferating cells. In
subcellular fractionationassays, endogenousFOXO1
and Ser249-phosphorylated FOXO1 in particular
were associated with the nuclear fraction in G2/M-
enriched cells (Fig. 4C and figs. S10C and S11C).
We also assessed the effect of phosphorylation of
endogenousFOXO1at Ser249 onFOXO-dependent
transcription in proliferating cells. Expression of
the FOXO-responsive reporter gene was higher
in G2/M-enriched cells than in G0/G1-enriched
cells (Fig. 4D and figs. S10D and S11D).
The gene promoter of the mitotic regulator
Polo-like kinase (Plk) harbors conserved FOXO
binding sites, and Plk transcription is induced by
FOXO3 at the G2/M transition (11). We therefore
tested whether the gene encoding Plk might rep-
resent a direct target of FOXO1 in proliferating
cells. Plk mRNA and protein levels were higher
at the G2/M transition than in the G0/G1 phase of
the cell cycle (Fig. 4, B and E, and figs. S10, B
and E, and S11, B and E). In addition, FOXO1
occupied the Plk gene promoter at G2/M but not
at G0/G1 (Fig. 4F and fig. S10F). FOXO RNAi
reduced endogenous Plk levels in cells (Fig. 4G).
Expression of the RNAi-resistant FOXO1-Res,
but not FOXO1-ResS249A, restored Plk expres-
sion in cells in the background of FOXO RNAi
(Fig. 4H and fig. S13). These results suggest that
the gene encoding Plk represents a G2/M-specific
target gene of Ser249-phosphorylated FOXO1 in
proliferating cells.
Our study reveals an intimate and conserved
signaling link between the protein kinase Cdk1
and the transcription factor FOXO1. Cdk1 phos-
phorylates FOXO1 at Ser249 and thereby disrupts
FOXO1’s interaction with 14-3-3 proteins, driv-
ing FOXO1 into the nucleus to activate a cell
death program of gene expression in neurons.
Cdk1-FOXO1 signaling also operates at the G2/M
transition of the cell cycle in proliferating cells
and thereby stimulates the expression of the mi-
totic regulator Plk. The Cdk1-FOXO1 signaling
pathway may thus have diverse functions in
cellular homeostasis, including regulation of neu-
ronal death and degeneration in brain develop-
ment and disease.
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TDP-43 Mutations in Familial and
Sporadic Amyotrophic Lateral Sclerosis
Jemeen Sreedharan,1* Ian P. Blair,3,4* Vineeta B. Tripathi,1* Xun Hu,1 Caroline Vance,1
Boris Rogelj,1 Steven Ackerley,1,2 Jennifer C. Durnall,3 Kelly L. Williams,3 Emanuele Buratti,5
Francisco Baralle,5 Jacqueline de Belleroche,6 J. Douglas Mitchell,7 P. Nigel Leigh,1
Ammar Al-Chalabi,1 Christopher C. Miller,1,2 Garth Nicholson,3,4,8* Christopher E. Shaw1*†
Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disorder characterized pathologically by
ubiquitinated TAR DNA binding protein (TDP-43) inclusions. The function of TDP-43 in the nervous
system is uncertain, and a mechanistic role in neurodegeneration remains speculative. We
identified neighboring mutations in a highly conserved region of TARDBP in sporadic and familial
ALS cases. TARDBPM337V segregated with disease within one kindred and a genome-wide scan
confirmed that linkage was restricted to chromosome 1p36, which contains the TARDBP locus.
Mutant forms of TDP-43 fragmented in vitro more readily than wild type and, in vivo, caused
neural apoptosis and developmental delay in the chick embryo. Our evidence suggests a
pathophysiological link between TDP-43 and ALS.
Amyotrophic lateral sclerosis (ALS, alsoknown as Lou Gehrig’s disease) is arelentlessly progressive and ultimately
fatal adult-onset disorder characterized patho-
logically by the degeneration of motor neurons
in the brain and spinal cord (1). ALS is familial
in 5 to 10% of cases (FALS) with an autosomal
dominant pattern of inheritance. Mutations in
CuZn superoxide dismutase (SOD1) are known
to cause ALS, and are detected in ~20% of
FALS and 3% of sporadic ALS (SALS) cases
(2, 3). Mice transgenic for mutant human SOD1
develop selective motor neuron degeneration
because of a toxic gain of function (4). Pure
FALS kindreds have been linked to chromo-
some 18q (5), 16q (6), and 20p (7). Other dom-
inant kindreds that have a phenotypic spectrum
ranging from pure ALS to pure frontotemporal
lobar dementia (FTLD) and individuals who
have features of both disorders have been linked
to chromosome 9p and 9q (8–10), but no patho-
genic mutations have been identified in these
kindreds.
The presence of ubiquitinated inclusions
(UBIs) in the perikaryon and proximal axon of
surviving spinal motor neurons is the patholog-
ical hallmark of ALS and indicates a failure of
the proteasome to recycle damaged proteins
(11). UBIs are also prominent in cortical neu-
rons within the frontal and temporal lobes in
patients with t-negative frontotemporal lobar
dementia (FTLD-U). Many individuals who pre-
sent with a pure ALS phenotype will have path-
ological features of FTLD-U and vice versa,
which also provides a circumstantial link be-
tween FTLD and ALS (12). The TAR DNA
binding protein (TDP-43) is the major protein
in UBIs in FTLD-U and ALS (13, 14). A
phosphorylated 25-kD C-terminal fragment of
TDP-43 and high-molecular-mass ubiquitinated
aggregates are enriched in detergent-resistant
fractions of FTLD-U and ALS brains. It is note-
worthy that those neurons with cytoplasmic in-
clusions have a substantial loss of nuclear TDP-43,
which raises the possibility that cleavage of full-
21 MARCH 2008 VOL 319 SCIENCE www.sciencemag.org1668
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